What is Adapttech?
Adapttech is a biomedical company dedicated to developing advanced technologies that empower healthcare providers. Their core mission is to improve the quality of life for individuals facing physical limitations through innovative solutions. The company's focus on assistive technologies positions it within a critical and expanding segment of the healthcare industry, addressing unmet needs and enhancing patient independence and well-being.
How much funding has Adapttech raised?
Adapttech has raised a total of $6.6M across 3 funding rounds:
Other Financing Round
$915K
Other Financing Round
$2.8M
Unspecified
$2.9M
Other Financing Round (2018): $915K, investors not publicly disclosed
Other Financing Round (2021): $2.8M led by Wealth Club, Wren Capital, ACF Investors, Midlands Engine, and Bionova Capital
Unspecified (2022): $2.9M supported by EIS funds, Wealth Club, and MEIF Proof of Concept & Early Stage Fund
Key Investors in Adapttech
EIS funds
EIS funds are investment vehicles that typically support early-stage companies, offering tax advantages to investors. Their participation suggests a belief in Adapttech's growth potential and a focus on innovation within the biomedical sector.
Wealth Club
Wealth Club is an investment platform that provides access to a range of investment opportunities, often including early-stage companies. Their involvement indicates a strategic interest in Adapttech's market and potential for significant returns.
Wren Capital
Wren Capital is an angel investor specializing in science, engineering, and software, with a focus on medical devices. Their investment in Adapttech aligns with their expertise in technically complex and innovative ventures.
What's next for Adapttech?
With a significant enterprise-level funding round, Adapttech is poised for accelerated growth and strategic expansion. This capital injection is expected to fuel further research and development, enhance manufacturing capabilities, and broaden market reach. The company's focus on empowering healthcare providers suggests a strategy aimed at integrating its technologies seamlessly into clinical workflows, thereby maximizing patient impact. Future developments will likely center on refining existing products and potentially introducing new solutions to address a wider spectrum of physical limitations, solidifying its position as a leader in assistive biomedical technology.
See full Adapttech company page
